Cupric and ferric ions inactivate HIV

Area of Science:

• Virology
• Inorganic Chemistry
• Biochemistry

Background:

• Human immunodeficiency virus (HIV-1) remains a significant global health challenge.
• Effective antiviral agents are crucial for managing HIV-1 infection.
• Understanding novel inactivation mechanisms is vital for therapeutic development.

Purpose of the Study:

• To investigate the virucidal efficacy of cupric (Cu(II)) and ferric (Fe(III)) ions against HIV-1.
• To compare the inactivation potential of these metal ions with existing antiviral agents.
• To assess the impact of metal ion treatment on HIV-1 infected cells.

Main Methods:

• Assessing HIV-1 inactivation in cell-free solutions using varying concentrations of Cu(II) and Fe(III).
• Treating HIV-1 infected cells with Cu(II) and Fe(III) and evaluating syncytia formation and p24 antigen synthesis.
• Measuring the 50% inactivation dose (D50) for HIV-1 with metal ions and comparing it to other agents.

Main Results:

• Cu(II) and Fe(III) demonstrated significant inactivation of cell-free HIV-1.
• The D50 for Cu(II) and Fe(III) was found to be higher than glutaraldehyde but lower than ethanol.
• Treatment of infected cells with 6 mM Cu(II) or Fe(III) completely inhibited syncytia formation and p24 antigen synthesis while maintaining cell viability.

Conclusions:

• Cupric and ferric ions possess potent virucidal properties against HIV-1.
• These metal ions offer a promising basis for developing novel virucidal formulations.
• The findings suggest a potential new strategy for controlling HIV-1 spread and infection.